tiprankstipranks
Trending News
More News >
iCoreConnect (ICCT)
OTHER OTC:ICCT
US Market

iCoreConnect (ICCT) AI Stock Analysis

Compare
174 Followers

Top Page

IC

iCoreConnect

(OTC:ICCT)

Rating:37Underperform
Price Target:
$0.00
▼(-100.00%Downside)
The overall score is heavily influenced by severe financial instability marked by high leverage, negative equity, and ongoing losses. The bearish technical analysis and poor valuation metrics further contribute to the low score. The Chapter 11 bankruptcy filing and Nasdaq delisting amplify the negative outlook.

iCoreConnect (ICCT) vs. SPDR S&P 500 ETF (SPY)

iCoreConnect Business Overview & Revenue Model

Company DescriptioniCoreConnect (ICCT) is a technology company that specializes in developing cloud-based software solutions for healthcare providers. The company offers a suite of products designed to enhance communication, improve workflow efficiency, and ensure compliance with industry regulations. Its core services include secure email, practice management software, and electronic health record (EHR) integration tools tailored to meet the unique needs of healthcare professionals.
How the Company Makes MoneyiCoreConnect generates revenue primarily through the subscription-based model of its software solutions. Customers pay recurring fees for access to the company's suite of cloud-based products, which include secure communication tools and practice management systems. These services are critical for healthcare providers who need to comply with privacy laws and improve operational efficiency. Additionally, iCoreConnect may collaborate with healthcare organizations through partnerships, expanding its reach and customer base. The company also benefits from ongoing updates and support services provided to its clients, which are factored into the subscription fees.

iCoreConnect Financial Statement Overview

Summary
iCoreConnect faces significant financial challenges with negative net income, deeply negative EBIT and EBITDA margins, high leverage, and negative stockholders' equity, indicating financial instability and substantial risks.
Income Statement
45
Neutral
The company shows substantial revenue growth, with a 31.9% increase in the latest year. However, net income remains negative, reflecting ongoing losses, and both EBIT and EBITDA margins are deeply negative, highlighting continued operational challenges.
Balance Sheet
30
Negative
The balance sheet reveals high leverage with a negative stockholders' equity, indicating financial instability. The debt-to-equity ratio is concerning due to the negative equity, and the equity ratio is negative, reflecting more liabilities than assets.
Cash Flow
40
Negative
Operating and free cash flows are negative, indicating cash burn. However, there was a slight improvement in free cash flow in the latest year. The high operating cash flow to net income ratio suggests cash flow is somewhat stable relative to reported losses.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue11.05M10.75M8.15M7.99M4.96M2.12M
Gross Profit7.46M8.25M6.12M5.74M3.38M1.11M
EBITDA-22.30M-26.73M-11.88M-3.51M-1.52M-2.35M
Net Income-29.07M-31.16M-15.55M-7.36M-5.80M-3.68M
Balance Sheet
Total Assets14.22M5.69M15.69M6.56M6.63M2.69M
Cash, Cash Equivalents and Short-Term Investments212.35K202.18K1.22M196.15K71.81K7.62K
Total Debt11.98M8.85M7.88M6.71M3.96M1.58M
Total Liabilities17.24M15.49M11.24M9.06M5.63M3.32M
Stockholders Equity-3.02M-9.79M4.44M-2.50M1.01M-628.94K
Cash Flow
Free Cash Flow-9.58M-4.63M-9.71M-1.57M-3.20M-1.81M
Operating Cash Flow-8.32M-3.23M-8.82M-1.27M-2.90M-1.27M
Investing Cash Flow-2.13M-539.42K-10.21M-293.96K-3.52M-917.90K
Financing Cash Flow10.20M2.75M20.06M1.69M6.48M1.75M

iCoreConnect Technical Analysis

Technical Analysis Sentiment
Negative
Last Price0.16
Price Trends
50DMA
1.36
Negative
100DMA
1.59
Negative
200DMA
3.16
Negative
Market Momentum
MACD
-0.34
Negative
RSI
28.88
Positive
STOCH
12.49
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For ICCT, the sentiment is Negative. The current price of 0.16 is below the 20-day moving average (MA) of 0.35, below the 50-day MA of 1.36, and below the 200-day MA of 3.16, indicating a bearish trend. The MACD of -0.34 indicates Negative momentum. The RSI at 28.88 is Positive, neither overbought nor oversold. The STOCH value of 12.49 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for ICCT.

iCoreConnect Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
54
Neutral
$3.96M-163.47%-100.00%78.91%
51
Neutral
$7.41B0.36-61.88%2.33%17.09%1.64%
41
Neutral
$2.28M-51.79%1.56%88.49%
37
Underperform
$755.95K-1718.32%31.83%-25.30%
27
Underperform
$9.44M-143.99%-64.77%43.53%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
ICCT
iCoreConnect
0.16
-17.08
-99.07%
LGMK
LogicMark
0.01
-15.85
-99.94%
HCTI
Healthcare Triangle
0.02
-0.46
-95.83%
HSCS
Heart Test Laboratories, Inc.
3.66
-1.40
-27.67%

iCoreConnect Corporate Events

Legal ProceedingsBusiness Operations and Strategy
iCoreConnect Files for Chapter 11 Bankruptcy
Negative
Jun 3, 2025

On June 2, 2025, iCoreConnect Inc. and its subsidiary filed for Chapter 11 bankruptcy to maintain control over their assets and operations while restructuring for future success. The filing aims to enhance procedural efficiency and ensure operational continuity, with outstanding note payables of over $10 million affected by the automatic stay provisions.

Delistings and Listing ChangesRegulatory Filings and Compliance
iCoreConnect Faces Nasdaq Delisting Due to Non-Compliance
Negative
May 22, 2025

iCoreConnect Inc. has been notified by Nasdaq’s Listing Qualifications Department regarding non-compliance with certain listing requirements due to not filing its Form 10-K for the period ending December 31, 2024. Despite being granted an extension to comply, the company received a determination letter on May 20, 2025, indicating its common stock will be delisted from Nasdaq due to failure to file required forms on time. Trading suspension will begin on May 22, 2025, and the company plans to have its stock quoted on the OTC Market.

Legal ProceedingsBusiness Operations and Strategy
iCoreConnect Reaches Settlement to Retain Assets
Neutral
May 12, 2025

On March 10, 2025, iCoreConnect Inc. received notice from PIGI Solutions, LLC about a public auction of the company’s personal property due to an alleged debt of $2,434,243. The company filed a lawsuit against PIGI and John Schneller, claiming fraudulent inducement into a finder’s fee agreement. On May 6, 2025, a Settlement and Mutual Release Agreement was reached, allowing iCoreConnect to retain control of its assets by making a payment of $3,099,747 by May 30, 2025, which would also lead to the dismissal of the lawsuit with prejudice.

Private Placements and Financing
iCoreConnect Secures $2.18M Revolving Loan Agreement
Neutral
Apr 11, 2025

On April 10, 2025, iCoreConnect, Inc. entered into a Revolving Loan Agreement with an institutional investor, allowing the company to draw up to $2,180,000 at its discretion. This agreement, which bears an 18% annual interest rate, is set to mature one year from the closing date. The company is also expected to pursue a public offering of at least $5,000,000. The agreement includes customary events of default and negative covenants, such as restrictions on repurchasing stock and incurring new debt beyond specified limits.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jun 27, 2025